Welsh School of Pharmacy

Anti-cancer Protides
Funder: 

Nucana Biomed Ltd

Value: £96,500
Duration: one year

Roles of trace amine-associated receptors in cardiovascular responses to dietary trace amines
Funder: 

British Heart Foundation

Value: £182,000
Duration: three years

Quantifying the extent of carbon nanotube transport across the pulmonary epithelium
Funder: 

Department of Health

Value: £117,584
Duration: 1 year

Pulmonary delivery of anti-microbial peptides (AMP’s): disposition within ex-vivo and in-vivo lung models
Funder: 

Defence Science and Technology Laboratory

Value: £99,599
Duration: 1 year

Microneedle based immunisation against pandemic influenza
Funder: 

This project is funded by the National Institute of Health (NIH).

Value: t.b.a.
Duration: 5 years

Combined use of AZD0530 and fulvestrant in breast cancer.
Funder: 

AstraZeneca UK Ltd.

Value: £59,724
Duration:  

Serotonin associated injury and survival signalling in myocardium: Receptor dependant and non receptor targets for cytoprotection
Funder: 

British Heart Foundation

Value: £141,823
Duration: three years

Studies on the exacerbation of pulmonary inflammation by viral infection
Funder: 

RespiVert Ltd

Value: £62,997
Duration: one year

Evaluation of the stability and bioavailability of anti-microbial peptides
Funder: 

Defence Science and Technology Laboratory

Value: £39,930
Duration: 1 year

Development of CYP26 Inhibitors as Neuroblastoma Therapeutics
Funder: 
Value: £109,646
Duration: 2 years

Cytoprotective regulation of intracellular calcium in myocardium by particulate and soluble guanylate cyclases
Funder:  
Value:  
Duration:  

The Cellular Basis of Neurodegeneration
Funder:  
Value:  
Duration: 3 years

Multiphase microfluidic devices for chemical synthesis and purification
Funder:  
Value:  
Duration: 3 years

An evaluation of steric hindrance of APP processing by 2B12 as a treatment for amyloid-related pathology in a murine preclinical model of Alzheimer’s disease
Funder:  The Alzheimer’s Society UK
Value:  
Duration: 3 years

Investigating the use of microneedles for the minimally invasive sub-epidermal delivery of novel therapeutic macromolecules.
Funder:  PhD studentship
Value:  
Duration: 3 years

A bedside, real time detection assay for Clostridium difficile in the faeces of hospitalized patients.
Funder:  
Value:  
Duration:  

The development of an antibody based therapy for Clostridium difficile
Funder:  IQ Corporation based in the Netherlands
Value: £15,000 pA
Duration: 3 years

Understanding the interactions of oxidizing agents with macromolecules and microbial cell components
Funder: Welsh School of Pharmacy, Cardiff University and an Industrial partner
Value:  
Duration:  

Acquired drug resistance and promotion of angiogenic responses in breast cancer
Funder: 
Value:  
Duration: